• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NZK
Click for more information
0.00% 25.5¢

NZ King Salmon Investments Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Packaged Foods

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NZK
Ann: NZK 1HY25 Half Year Results Announcement Details 		02/09/24 0 60
02/09/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  60 
NZK
Ann: Change of External Auditor 		02/07/24 0 109
02/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  109 
NZK
Ann: Grant of Performance Share Rights 		01/07/24 0 80
01/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  80 
NZK
Ann: NZK - 2024 Annual Shareholder Meeting Results 		19/06/24 0 102
19/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  102 
NZK
Ann: ASM Meeting Materials 		19/06/24 0 137
19/06/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  137 
NZK
Ann: Climate-Related Disclosures FY24 		29/05/24 0 112
29/05/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  112 
NZK
Ann: Notice of Annual Shareholders Meeting 		20/05/24 0 112
20/05/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  112 
NZK
Ann: Ongoing Disclosure Notice - Victoria Taylor 		16/05/24 0 138
16/05/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  138 

See All Discussions arrow Created with Sketch.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
25.5¢ 		Change
0.000(0.00%) 		Mkt cap ! n/a
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $6.353K 26.01K

Buyers (Bids)

No. Vol. Price($)
0 1886 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 57415 0
Last trade - 12.59pm 20/09/2024 (20 minute delay) ?
NZK (NZSX) Chart

Top Stories

Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs

Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.